Published Online: Friday, December 1, 2006

The dual-status Rx/OTC version of Plan B (levonorgestrel) is now available in pharmacies. Duramed Pharmaceuticals Inc, a wholly owned subsidiary of Barr Pharmaceuticals, began shipping the medication in mid November.

The dual-label product is approved for OTC sale for women aged 18 and older. The Plan B OTC/Rx version will be marketed as a single package, which will allow for an Rx label to be affixed to the package when dispensed to girls aged 17 and younger. Because Plan B remains a prescription product for adolescents, it will be available only in retail pharmacy outlets from behind the counter and under the supervision of a pharmacist.

The FDA granted Duramed 3-year exclusivity for Plan B, based on clinical studies conducted for OTC approval. The exclusivity is valid until August 2009.

Visit ePharmacy Times at for a related story on Plan B.

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues